These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 3185486

  • 1. [Histopathological and immunohistochemical studies on the elevation mechanism of cancer associated antigens, CEA and CA19-9, in gastric cancer patients].
    Tabuchi Y, Deguchi H, Saitoh Y.
    Nihon Geka Gakkai Zasshi; 1988 Aug; 89(8):1181-91. PubMed ID: 3185486
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Histopathological and immunohistochemical studies on the elevation mechanism of cancer associated antigens, CEA and CA19-9, in patients with colorectal cancer].
    Deguchi H, Tabuchi Y, Saitoh Y.
    Nihon Geka Gakkai Zasshi; 1988 May; 89(5):671-83. PubMed ID: 3166103
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Patients with high risk of hematogenous metastasis and recurrence in colorectal cancer: correlation with histopathologic variables and tumor markers, CEA and CA19-9, in peripheral and draining venous blood].
    Deguchi H, Tabuchi Y, Saitoh Y.
    Nihon Geka Gakkai Zasshi; 1991 Jun; 92(6):664-71. PubMed ID: 1886571
    [Abstract] [Full Text] [Related]

  • 7. Carcinoembryonic antigen levels of portal blood in gastric cancer patients.
    Tabuchi Y, Deguchi H, Saitoh Y.
    J Surg Res; 1989 Jul; 47(1):81-6. PubMed ID: 2739403
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Significance of CA72-4 as a follow up of recurrent gastric cancer--comparison with CEA and CA19-9].
    Takahashi Y, Mai M.
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):515-8. PubMed ID: 1558402
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Evaluation of CA72-4 as a tumor marker in patients with gastric cancer].
    Ubukata H, Katano M, Motohashi G, Kasuga T, Takemura A, Tabuchi T, Tabuchi T.
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1821-4. PubMed ID: 14619529
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Predictive factors for preoperative serum levels of sialy Lewis(x), sialyl Lewis(a) and sialyl Tn antigens in gastric cancer patients.
    Nakagoe T, Sawai T, Tsuji T, Jibiki MA, Nanashima A, Yamaguchi H, Yasutake T, Ayabe H, Arisawa K, Ishikawa H.
    Anticancer Res; 2002 Oct; 22(1A):451-8. PubMed ID: 12017332
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.